Arrowhead Pharma (ARWR) Beats Q1 Earnings Estimates by $0.20

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly earnings results on February 05, 2026 that exceeded analyst expectations.

The Healthcare company reported earnings per share of $0.22, beating the consensus estimate of $0.02 by $0.20 per share. Revenue came in at $264.0M, beating the estimate of $256.6M.

Arrowhead Pharma's stock moved following the earnings release. The stock currently trades at $64.52 with a market capitalization of $9.8B.